Influence of Obesity and Gastric Bypass on Medication Absorption
NCT ID: NCT01571180
Last Updated: 2017-05-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
100 participants
OBSERVATIONAL
2012-04-30
2017-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Characteristics of Patients With Nonsurgical Complications After Bariatric Surgery and Quality of Life
NCT05957237
Study on Mechanisms of Changes in Liver Disease and Sex Steroid Metabolism During Weight Loss
NCT02964780
Effects of LRYGB on Pharmacokinetics of Nine CYP Probe Drugs
NCT03563287
Multidisciplinary Approach and Counseling of the Obese Patient Before and After Bariatric Surgery
NCT02156830
Gastrointestinal Physiological Conditions in Obesity and After Bariatric Surgery
NCT03783052
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The following aspects will be investigated:
* Medication The investigators have composed a questionnaire to examine which drugs the patients use, adherence, information received about medication and from whom,…
* Clinical parameters Every consultation, concentrations of hemoglobin, iron, hepcidin, vitamin B12,…. and a 24h urine collection to determine calcium excretion will be collected.
* Dietary intake The investigators will ask patients to keep a food record during two non-consecutive days preceding each consultation. In this food record patients have to note all consumed foods and beverages with the right/estimated amounts. This makes it possible to see the changes of the composition of the meals before and after RYGB.
* Body composition
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Gastric Bypass
Obese patients who have scheduled a gastric bypass
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Use of at least one chronic drug (including contraception)
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
KU Leuven
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ina Gesquiere
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ina Gesquiere, PhD Student
Role: PRINCIPAL_INVESTIGATOR
Katholieke Universiteit Leuven - Centre for Pharmacotherapy
Veerle Foulon, Pharm PhD
Role: STUDY_DIRECTOR
Katholieke Universiteit Leuven - Centre for Pharmacotherapy
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
KU Leuven - Centre for Pharmacotherapy
Leuven, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
s53782
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.